Log In

Term Description

The response of the tumor to neoadjuvant treatment, such as chemotherapy or endocrine therapy. The response of invasive breast carcinoma to neoadjuvant therapy is associated with increased disease-free and overall survival.

LOINC Names Get Info

Fully-Specified Name
Response to neoadjuvant therapy:Find:Pt:Breast cancer specimen:Ord:
Long Common Name
Response to neoadjuvant therapy in Breast cancer specimen Qualitative
Short Name
Resp to neoadjvt therapy Br ca spec Ql
Display Name
Response to neoadjuvant therapy Ql (Breast cancer specimen)
Consumer Name Alpha Get Info
Response to neoadjuvant therapy, Breast cancer specimen

Part Model Get Info

  • Component
    Response to neoadjuvant therapy
    LP222094-7
    • Analyte
      Response to neoadjuvant therapy
      LP222094-7
      • Component Numerator
        Response to neoadjuvant therapy
        LP222094-7
        • Component Numerator Core
          Response to neoadjuvant therapy
          LP222094-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Find
    LP6813-2
  • Time
    Pt
    LP6960-1
  • System
    Breast cancer specimen
    LP247851-1
    • System Core
      Breast cancer specimen
      LP247851-1
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    NULL
     

Example Answer List: LL4386-0

Source: College of American Pathologists
AnswerCodeScoreAnswer ID
No known presurgical therapyLA27236-1
No definite response to presurgical therapy in the invasive carcinomaLA27237-9
Probable or definite response to presurgical therapy in the invasive carcinomaLA27238-7
No residual invasive carcinoma is present in the breast after presurgical therapyLA27239-5

Basic Attributes

Class
PATH
Type
Laboratory
First Released
Version 2.61
Last Updated
Version 2.61 (ADD)
Order vs. Observation
Observation

Member of these Panels

LOINCLong Common Name
85904-1Cancer pathology panel - Breast cancer specimen by CAP cancer protocols

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Neoadjuvantní terapie odpověď:Nález:Časový bod:Vzorek karcinomu prsu:Ordinální:
el-GRGreek (Greece)Ανταπόκριση στη νεοεπικουρική θεραπεία:Εύρεση:Pt:Δείγμα καρκίνου του μαστού:Ord:
Synonyms: Ord PATH Pt Ανταπόκριση στη νεοεπικουρική θεραπεία Δείγμα Δείγμα καρκίνου Δείγμα καρκίνου του μαστού Εύρεση Καρκίνος Μαστός
es-ESSpanish (Spain)Respuesta a la terapia neoadyuvante:Hallazgo:Punto temporal:Muestra de cancer de mama:Ord:
es-MXSpanish (Mexico)Respuesta a la terapia neoadyuvante:Hallazgo:Punto temporal:Muestra de cáncer de mama:Ordinal:
it-ITItalian (Italy)Risposta a terapia neoadiuvante:Osservazione:Pt:Tumore della mammella, campione:Ord:
Synonyms: Campione di tumore Campione di tumore della mammella Neoplasia maligna Osservazione Patologia Petto Punto nel tempo (episodio)
zh-CNChinese (China)对新辅助疗法的反应:发现:时间点:乳腺癌标本:序数型:
Synonyms: 乳房 乳腺癌（乳癌）标本（样本、样品、试样） 供检查用的材料;待检物;待试验物;样品;样本;试料;试样 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 发现是一个原子型临床观察指标，并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型，而对于叙述型文本之中所报告的发现，则可能是叙述型。;发现物;所见;结果;结论 受检物 对新辅助疗法（新辅助治疗）的反应（响应、应答）;新辅助疗法（新辅助治疗）的效果 时刻;随机;随意;瞬间 样品 样本 癌 癌（癌症、癌变）标本（样本、样品、试样） 试样

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=85323-4